&
A significant number of pathogens exist that are resistant to currently available antibacterial drugs. In addition, there has been an increase in the number of patients with impaired immunity, reflected by a change in the incidence of various infectious diseases. In order to try to rectify this situation, new targets must be identified for drug development. A number of potential targets have been suggested. Details of these were presented at IBC USA’s Antibiotic Discovery conference [ Philadelphia, US; June 1995 ].
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Chwieduk, C. New targets identified for antibacterial development. Inpharma Wkly. 995, 9–10 (1995). https://doi.org/10.2165/00128413-199509950-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199509950-00015